Viewing nowCombinationTradjian Tablet 25/5 mg (Empagliflozin, Linagliptin)
Empagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 202302839 · Approved 2023.09.27
Improvement of glycemic control in type 2 diabetes mellitus
This medication is a treatment that helps control blood glucose in patients with type 2 diabetes by using Empagliflozin and Linagliptin together. It aids in effectively managing blood glucose when combined with dietary control and exercise therapy.
The recommended starting dose of this medicine is empagliflozin 10 mg/linagliptin 5 mg once daily. If empagliflozin 10 mg/linagliptin 5 mg is tolerated and additional glycemic control is needed, the dose of this medicine may be increased to 25/5 mg once daily. Patients switching to this medicine from concomitant empagliflozin and linagliptin therapy should receive their previous doses. This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose of this medicine, take it as soon as you remember. However, if it is within 12 hours of the next dose, skip the missed dose and take the next dose at the regularly scheduled time. Do not take a double dose in one day. Patients with renal impairment This medicine is not recommended for patients with an estimated glomerular filtration rate (eGFR) of less than 45 ml/min/1.73m2 for the purpose of improving glycemic control. No dose adjustment is necessary in patients with an estimated glomerular filtration rate of 45 ml/min/1.73m2 or higher. Patients with hepatic impairment No dose adjustment is necessary in patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment, as it has not been studied in this population. Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older.
This medication should not be administered to certain patients. For example, individuals who are allergic to the main ingredients or components of this drug, patients with type 1 diabetes, diabetic ketoacidosis, and those undergoing dialysis should not use this medication. Patients with impaired renal function may experience altered effectiveness of this drug, so renal function should be assessed before administration and monitored regularly. Additionally, it should only be used cautiously in patients with mild to moderate heart failure and is not recommended for patients with severe heart failure. This medication may cause rare skin conditions such as acute pancreatitis or bullous pemphigoid, so if such symptoms occur, discontinue use immediately and consult a physician. The most common side effect is a urinary tract infection, and other effects such as hypoglycemia, dehydration, skin rash, and increased urination may occur. Care should be taken as the risk of hypoglycemia may increase when taken together with insulin or sulfonylureas. Serious metabolic acidosis called ketoacidosis may occur, so during the use of this medication, if symptoms such as nausea, vomiting, abdominal pain, or shortness of breath arise, inform medical professionals immediately. Elderly patients, those with low blood pressure, and individuals at risk for fluid loss should be cautious of dehydration and hypotension when taking this medication, and may temporarily discontinue use if necessary. Furthermore, this medication may increase the risk of genital infections, so those with a history of infections should monitor symptoms closely and seek treatment if needed. Pregnant or breastfeeding women are advised not to take this medication, and breastfeeding should be discontinued if taking this medication. It is not recommended for children and adolescents under 18 years of age, as safety and efficacy have not been established. In case of overdose, seek medical attention immediately, and information on whether hemodialysis can remove this drug's components is limited. Finally, this medication should be kept out of reach of children and stored in its original container to maintain its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 to 30 degrees Celsius. This ensures the medication's efficacy is preserved safely.
Light pink triangular film-coated tablet
10 tablets/PPT [(10 tablets/PPT x 1)], 30 tablets/PPT [(10 tablets/PPT x 3)], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Dongkoo Bio Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Empagliflozin 25mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Empagliflozin 10mg · Linagliptin 5mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.